Abstract
Gastric cancer is known as the fourth most common cancer and the second main cause of cancer-related deaths. Finding a suitable system of drug delivery for effective treatment in gastric cancer chemotherapy has been of great value in recent years. Platinum-based drugs are among the most popular drugs for solid tumors chemotherapeutic agents in the clinic. However, severe side effects such as neurotoxicity and etc. It limits the use of extreme doses of the drug. To overcome these issues Pt(IV) prodrugs and nanocarriers as the platinum delivery systems might represent the next generation of platinum-based drugs. The present assay aimed to develop a nanoparticles-based Pt(IV) prodrug delivery system to enhance the In Vitro cytotoxicity and In Vivo nursing care of gastric cancer. The characterizations depicted that the synthesized formulation exhibited beneficial physicochemical properties. The biological assays showed that the synthesized formulation exhibited a sustained drug release profile. Moreover, the application of the synthesized formulation enhanced the In Vitro cytotoxicity and In Vivo nursing care of gastric cancer. The results suggest that the developed formulation is one of the most important candidates for nursing care is to treat this kind of diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
